
Monday, April 28, 2014 12:05:50 PM
No trials were identified that compared a combination of Omega-3 fatty acid with statin to intensification of statin monotherapy; therefore, the strength of evidence is insufficient for all outcomes.
Once again, American researchers refuse to believe Japanese are part of the human race! No mention of JELIS? Great meta-search, guys.
The Thought Police: To censor and protect. Craig Bruce

Liked By
Spread the love. Be the first to like this post!
Recent AMRN News
- Reconstituted Amarin Board Ready for the Challenge of Unlocking True Potential of VASCEPA®/VAZKEPA® (Icosapent Ethyl) • GlobeNewswire Inc. • 03/16/2023 12:00:00 PM
- Nightfood, Inc. (OTCQB: NGTF) now in Sonesta International Hotels Multiple Brands • InvestorsHub NewsWire • 03/13/2023 11:35:55 AM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 03/10/2023 11:34:16 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 03/10/2023 11:34:01 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 03/10/2023 11:33:42 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 03/10/2023 11:33:30 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 03/10/2023 11:32:42 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/08/2023 01:31:04 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/08/2023 01:30:53 PM
- Amarin Announces Board Departures • GlobeNewswire Inc. • 03/06/2023 09:05:43 PM
- Amarin Highlights New Evidence of Therapeutic Value of EPA in Reducing Cardiovascular Events in At-Risk Patients Presented at ACC.23/WCC • GlobeNewswire Inc. • 03/06/2023 01:00:00 PM
- Amarin Announces New REDUCE-IT® Data at ACC.23/WCC Showing Benefit of VASCEPA®/VAZKEPA® (Icosapent Ethyl) in High-Risk Patients with a Recent Acute Coronary Syndrome Event • GlobeNewswire Inc. • 03/05/2023 03:21:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/02/2023 01:46:36 PM
- Annual Report (10-k) • Edgar (US Regulatory) • 03/01/2023 12:38:15 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/01/2023 12:07:12 PM
- Amarin Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/01/2023 12:00:00 PM
- Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) • Edgar (US Regulatory) • 02/28/2023 04:29:47 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 02/28/2023 04:20:41 PM
- Sarissa Capital Wins Proxy Contest Against Amarin by Huge Landslide • Business Wire • 02/28/2023 03:39:00 PM
- Amarin Announces Preliminary Voting Results Following 2023 General Meeting of Shareholders • GlobeNewswire Inc. • 02/28/2023 03:38:06 PM
- Amarin and CSL Seqirus Announce Exclusive License and Distribution Agreement to Commercialize VAZKEPA® (Icosapent Ethyl) in Australia and New Zealand • GlobeNewswire Inc. • 02/28/2023 01:00:55 PM
- Amarin Sets the Record Straight on Sarissa’s Latest Misstatements • GlobeNewswire Inc. • 02/27/2023 09:29:23 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 02/27/2023 09:06:19 PM
- Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) • Edgar (US Regulatory) • 02/27/2023 09:06:16 PM
- Amarin Corporation to Present New Data Evaluating VASCEPA®/VAZKEPA® (Icosapent Ethyl) at ACC.23/WCC • GlobeNewswire Inc. • 02/27/2023 01:00:00 PM
FEATURED Lifecycle Assessment by Benchmark Shows TMC's NORI-D Nodule Project Could Outperform Land-Based Routes of Producing Nickel, Copper and Cobalt in Almost Every Impact Category Analyzed • Mar 22, 2023 1:44 PM
FEATURED Fineqia Announces Partnership with Paris Blockchain Week to Accelerate Digital Asset Innovation • Mar 22, 2023 10:03 AM
FEATURED E-Cite and ClearMarket Launch Nationwide EV Distribution Network Becoming the First All EV Dealership Opening in the Cerritos Auto Square, the World's Largest Automall • Mar 22, 2023 9:41 AM
FEATURED Electromedical Announces $1.36M Net Proceeds from Building Sale to Fund WellnessPro Infinity ™ Launch and Convertible Note Retirement. • Mar 22, 2023 7:04 AM
HealthLynked Corp. Awarded Patent 11,600,395 for "Secure Patient Access via Healthcare Service Provider Specific Wireless Access Point" • HLYK • Mar 21, 2023 8:00 AM
Predictmedix Announces US Patent Grant for AI-Powered Impairment Detection Technology for Cannabis and Alcohol Screening • PMEDF • Mar 21, 2023 7:56 AM